Skip to content

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Stryker logo
StrykerSYK
$3.81B+1.8%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$139.55M+14.7%
Alphatec Holdings logo
Alphatec HoldingsATEC
$136.48M+17.7%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$41.94M+11.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's gross profit?
Xtant Medical Holdings (XTNT) reported gross profit of $11.97M in Q1 2026.
How has Xtant Medical Holdings's gross profit changed year-over-year?
Xtant Medical Holdings's gross profit decreased by 40.9% year-over-year, from $20.24M to $11.97M.
What is the long-term trend for Xtant Medical Holdings's gross profit?
Over 4 years (2021 to 2025), Xtant Medical Holdings's gross profit has grown at a 26.9% compound annual growth rate (CAGR), from $32.49M to $84.27M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.